Add-on treatment with verapamil in pharmacoresistant canine epilepsy.
about
Antiepileptic drugs' tolerability and safety--a systematic review and meta-analysis of adverse effects in dogsP-glycoprotein alters blood-brain barrier penetration of antiepileptic drugs in rats with medically intractable epilepsy.Recent Advances in Radiotracer Imaging Hold Potential for Future Refined Evaluation of Epilepsy in Veterinary Neurology.
P2860
Add-on treatment with verapamil in pharmacoresistant canine epilepsy.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh-hant
name
Add-on treatment with verapamil in pharmacoresistant canine epilepsy.
@en
Add-on treatment with verapamil in pharmacoresistant canine epilepsy.
@nl
type
label
Add-on treatment with verapamil in pharmacoresistant canine epilepsy.
@en
Add-on treatment with verapamil in pharmacoresistant canine epilepsy.
@nl
prefLabel
Add-on treatment with verapamil in pharmacoresistant canine epilepsy.
@en
Add-on treatment with verapamil in pharmacoresistant canine epilepsy.
@nl
P2860
P1433
P1476
Add-on treatment with verapamil in pharmacoresistant canine epilepsy.
@en
P2093
Melanie Jambroszyk
P2860
P304
P356
10.1111/J.1528-1167.2010.02886.X
P577
2011-01-10T00:00:00Z